Skip to main content

Aggregator

The two cultures meet again

4 months 1 week ago
Science, Volume 386, Issue 6727, Page 1218-1221, December 2024.

Anne Milasincic Andrews,
Jon Christensen,
Paul S. Weiss,
Floor Broekgaarden,
Colin Camerer,
AJ Addae






Confronting risks of mirror life

4 months 1 week ago
Science, Volume 386, Issue 6728, Page 1351-1353, December 2024.

Katarzyna P. Adamala,
Deepa Agashe,
Yasmine Belkaid,
Daniela Matias de C. Bittencourt,
Yizhi Cai,
Matthew W. Chang,
Irene A. Chen,
George M. Church,
Vaughn S. Cooper,
Mark M. Davis,
Neal K. Devaraj,
Drew Endy,
Kevin M. Esvelt,
John I. Glass…

"Current and emerging drug therapies in Alzheimer's disease: A pathophysiological Perspective"

4 months 1 week ago
The analytical and experimental investigation of several targets and biomarkers that help in explaining significant cognitive deficits, covering drug development and precision medicine aimed at different chronic neurodegenerative conditions such as Alzheimer's disease (AD), Parkinson's disease, synaptic dysfunction, brain damage from neuronal apoptosis, and other disease pathologies; this served as the foundation for all phase studies. The focus of current therapeutic approaches is on developing...
Aparajita Aparajita

The complex relationship between gut microbiota and Alzheimer's disease: A systematic review

4 months 1 week ago
Alzheimer's disease (AD) is a progressive, degenerative disorder of the central nervous system. Despite extensive research conducted on this disorder, its precise pathogenesis remains unclear. In recent years, the microbiota-gut-brain axis has attracted considerable attention within the field of AD. The gut microbiota communicates bidirectionally with the central nervous system through the gut-brain axis, and alterations in its structure and function can influence the progression of AD....
Xuan-Peng Zhou